Amy K. Barczak
- Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology 13
- SARS-CoV-2 and COVID-19 Research 5
- SARS-CoV-2 detection and testing 3
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 3
- Epidemiology top 5%
- Mycobacterium research and diagnosis 10
-
- Neuroscience and Neuropharmacology Research 7
- Immunology top 5%
-
- Receptor Mechanisms and Signaling 4
- Ion channel regulation and function 3
- Co-authors
- Claudia MancaGilla KaplanClifton E. BarryMichael B. ReedPilar DomenechHua SuBarry N. KreiswirthDeborah T. Hung
- Partner nations
- United StatesSouth AfricaUnited Kingdom
In The Last Decade
Amy K. Barczak
33 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Infectious Diseases 1.2k
- Molecular Medicine 164
- Epidemiology 932
- Cellular and Molecular Neuroscience 461
- Immunology 493
Countries citing papers authored by Amy K. Barczak
This map shows the geographic impact of Amy K. Barczak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy K. Barczak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy K. Barczak more than expected).
Fields of papers citing papers by Amy K. Barczak
This network shows the impact of papers produced by Amy K. Barczak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy K. Barczak. The network helps show where Amy K. Barczak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amy K. Barczak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 40 | |
| 4 | 2024 | 8 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 11 | |
| 7 | 2021 | 42 | |
| 8 | 2021 | 26 | |
| 9 | 2020 | 92 | |
| 10 | 2017 | 77 | |
| 11 | 2015 | 77 | |
| 12 | 2015 | 6 | |
| 13 | 2014 | 198 | |
| 14 | 2005 | 240 | |
| 15 | 2005 | 54 | |
| 16 | 2003 | 135 | |
| 17 | 2000 | 128 | |
| 18 | 1999 | 150 | |
| 19 | 1998 | 28 | |
| 20 | 1998 | 41 |
About Amy K. Barczak
Amy K. Barczak is a scholar working on Infectious Diseases, Molecular Medicine and Cellular and Molecular Neuroscience, having authored 34 papers that have together received 2.7k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (13 papers), Mycobacterium research and diagnosis (10 papers), Neuroscience and Neuropharmacology Research (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Receptor Mechanisms and Signaling (4 papers), Antibiotic Resistance in Bacteria (3 papers), SARS-CoV-2 detection and testing (3 papers) and Ion channel regulation and function (3 papers). The work is most often cited by research in Infectious Diseases (1.2k citations), Molecular Medicine (164 citations) and Epidemiology (932 citations). Amy K. Barczak has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Claudia Manca, Gilla Kaplan, Clifton E. Barry, Michael B. Reed, Pilar Domenech, Hua Su, Barry N. Kreiswirth, Deborah T. Hung, Wendy Macias‐Konstantopoulos and Anjali M. Rajadhyaksha. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.